<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="15543">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00136812</url>
  </required_header>
  <id_info>
    <org_study_id>NIDA-18691-1</org_study_id>
    <secondary_id>5K23DA018691-05</secondary_id>
    <secondary_id>K23-18691-1</secondary_id>
    <nct_id>NCT00136812</nct_id>
  </id_info>
  <brief_title>Treating Tobacco Dependence in Inpatient Psychiatry - 1</brief_title>
  <official_title>Treating Tobacco Dependence in Inpatient Psychiatry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test in a randomized clinical trial (N=300) a series of
      hypotheses concerning the efficacy of an extended expert-system intervention plus nicotine
      replacement therapy (NRT) for treating tobacco dependence among patients hospitalized on a
      smoke-free psychiatric unit. It is hypothesized that the intervention will be more effective
      than the enhanced standard care control condition (on-unit NRT with self-help brochure) in
      producing biochemically verified abstinence from cigarettes at 3-, 6-, 12-, and 18-months
      follow up. Additionally, intervention participants will exhibit greater stage progression,
      commitment to abstinence, and delay in relapse to smoking following hospital discharge,
      factors predictive of future success with quitting smoking. Smoking cessation treatments
      have been shown to be highly cost-effective with the general population of smokers, and cost
      is likely to be a consideration in efforts to incorporate additional services into an
      inpatient psychiatric setting. Therefore, a secondary specific aim is to model the
      cost-effectiveness of the smoking cessation intervention. Intervention efficacy will be
      examined in a university-based psychiatric inpatient unit. A smaller pilot study (N=48) will
      examine translation of the intervention to a county hospital serving a more diversified
      patient population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>7 Day Point Prevalence of Cigarette Abstinence</measure>
    <time_frame>1 week, 3 mo, 6 mo, 12 mo, and 18 mo post-baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">224</enrollment>
  <condition>Tobacco Use Cessation</condition>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>enhanced standard care control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tobacco Use Cessation</intervention_name>
    <description>This intervention consists of nicotine patch therapy during hospitalization; a stage-based self-help manual; an individualized, expert-system, feedback report at intake, 3 months and 6 months post-hospitalization with carbon copies sent to participants' outpatient clinicians; and an individual 30-min smoking cessation counseling sessions during hospitalization. Additionally, up to 10 weeks of nicotine patch is provided to intervention participants intending to stay quit following hospital discharge.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Men and women over 18 years of age hospitalized on an inpatient psychiatric unit who
        report smoking at least 5 cigarettes per day. Other inclusion criteria include: smoking at
        least 100 cigarettes in one's lifetime, residing in the San Francisco Bay Area with no
        plan to relocate outside of the area in the next 18 months, and access to a telephone for
        scheduling follow up assessments.

        Exclusion Criteria:

        Dementia or other brain injury precluding ability to participate; non-English speaking;
        severe agitation, psychosis, or hostility; and medical contraindications to nicotine
        replacement therapy (NRT). Recruitment of acutely psychotic, manic, or hostile patients
        will be delayed until there is significant reduction of these symptoms. Medical
        contraindications are: myocardial infarction in the preceding 3 months, unstable angina
        pectoris, liver or kidney disease, current pregnancy or breast feeding, allergies to
        adhesives, or other medical conditions that the medical team deems incompatible with NRT
        use.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Judith Prochaska</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Langley Porter Psychiatric Institute</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <lastchanged_date>February 22, 2016</lastchanged_date>
  <firstreceived_date>August 25, 2005</firstreceived_date>
  <firstreceived_results_date>February 22, 2016</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Judith Prochaska</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>tobacco</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Adult smokers (N=224) were recruited between July 2006 and December 2008 from the adult inpatient psychiatry unit at the Langley Porter Psychiatric Institute (LPPI) located on the University of California, San Francisco (UCSF) medical school campus.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>Usual care provided NRT during hospitalization with brief cessation advice.</description>
        </group>
        <group group_id="P2">
          <title>Brief Treatment</title>
          <description>The intervention included a Transtheoretical Model-tailored computerized program and print workbook; brief on-unit counseling session; and nicotine replacement therapy (NRT) during hospitalization with access to 10 weeks of NRT post-hospitalization.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="111"/>
                <participants group_id="P2" count="113"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="111"/>
                <participants group_id="P2" count="113"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Usual care provided NRT during hospitalization with brief cessation advice.</description>
        </group>
        <group group_id="B2">
          <title>Brief Treatment</title>
          <description>The intervention included a Transtheoretical Model-tailored computerized program and print workbook; brief on-unit counseling session; and nicotine replacement therapy (NRT) during hospitalization with access to 10 weeks of NRT post-hospitalization.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="111"/>
                <measurement group_id="B2" value="113"/>
                <measurement group_id="B3" value="224"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="111"/>
                <measurement group_id="B2" value="113"/>
                <measurement group_id="B3" value="224"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="39.9" spread="14.1"/>
                <measurement group_id="B2" value="39.9" spread="13.5"/>
                <measurement group_id="B3" value="39.9" spread="14"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="36"/>
                <measurement group_id="B2" value="48"/>
                <measurement group_id="B3" value="84"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="71"/>
                <measurement group_id="B2" value="63"/>
                <measurement group_id="B3" value="134"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="111"/>
                <measurement group_id="B2" value="113"/>
                <measurement group_id="B3" value="224"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>7 Day Point Prevalence of Cigarette Abstinence</title>
        <time_frame>1 week, 3 mo, 6 mo, 12 mo, and 18 mo post-baseline</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Usual care provided NRT during hospitalization with brief cessation advice.</description>
          </group>
          <group group_id="O2">
            <title>Brief Treatment</title>
            <description>The intervention included a Transtheoretical Model-tailored computerized program and print workbook; brief on-unit counseling session; and nicotine replacement therapy (NRT) during hospitalization with access to 10 weeks of NRT post-hospitalization.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="111"/>
                  <measurement group_id="O2" value="113"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>7 Day Point Prevalence of Cigarette Abstinence</title>
            <units>percentage of participants</units>
            <param>Number</param>
            <dispersion>95% Confidence Interval</dispersion>
            <category_list>
              <category>
                <sub_title>3 month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.2" lower_limit="2" upper_limit="4.4"/>
                  <measurement group_id="O2" value="13.9" lower_limit="12.7" upper_limit="15.1"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>6 month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="6.5" lower_limit="5.3" upper_limit="7.7"/>
                  <measurement group_id="O2" value="14.4" lower_limit="13.2" upper_limit="15.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>12 month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="10.9" lower_limit="9.7" upper_limit="12.1"/>
                  <measurement group_id="O2" value="19.4" lower_limit="18.2" upper_limit="20.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>18 month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.7" lower_limit="6.5" upper_limit="8.9"/>
                  <measurement group_id="O2" value="20.0" lower_limit="18.8" upper_limit="21.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.05</p_value>
            <method>Odds ratio</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>1: Enhanced Standard Care Control</title>
          <description>enhanced standard care control</description>
        </group>
        <group group_id="E2">
          <title>2: Intervention</title>
          <description>intervention
Tobacco Use Cessation: This intervention consists of nicotine patch therapy during hospitalization; a stage-based self-help manual; an individualized, expert-system, feedback report at intake, 3 months and 6 months post-hospitalization with carbon copies sent to participants' outpatient clinicians; and an individual 30-min smoking cessation counseling sessions during hospitalization. Additionally, up to 10 weeks of nicotine patch is provided to intervention participants intending to stay quit following hospital discharge.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="113"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="111"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="113"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Judith Prochaska, PhD, MPH; Associate Professor</name_or_title>
      <organization>Stanord University</organization>
      <phone>650-724-3608</phone>
      <email>JPro@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
